Target intelligence / Profile preview

Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) (CASP3 mRNA 3'UTR)

Target
CASP3 mRNA 3'UTR
Molecular classification
Messenger RNA, Untranslated region, RNA regulatory element
01

Overview

The Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) is a critical regulatory segment of the CASP3 transcript that governs the expression of the executioner caspase-3 protein (UniProt P42574). This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins, which collectively modulate mRNA stability and translation efficiency (NCBI Gene ID: 836). In many cancers, overexpression of oncogenic miRNAs like miR-21 targets this 3'UTR to suppress Caspase-3 production, thereby facilitating apoptosis evasion and chemoresistance (Zhu et al., 2008, Cell Research; PMID: 18443608). Conversely, in neurodegenerative conditions or acute injuries like stroke, the dysregulation of this region can lead to pathological overexpression of Caspase-3, driving excessive cell death (PubMed: 21471066). Therapeutic strategies targeting the CASP3 mRNA 3'UTR include the use of antisense oligonucleotides (ASOs) or miRNA mimics to either restore or inhibit Caspase-3 levels depending on the disease context (NCBI PMC: PMC3921586). While promising, these approaches face challenges such as ensuring tissue-specific delivery and minimizing off-target effects on other mRNA transcripts that share similar regulatory sequences (Nature Reviews Drug Discovery, 2020).

Other names
Caspase-3 3'UTRCASP3 3'-untranslated regionCaspase-3 3'-UTRCPP32 mRNA 3'UTRSCA-1 mRNA 3'UTR
02

Mechanism of action

Modulation of mRNA stability and translation efficiency through competitive binding or RNA interference (RNAi) at the 3' untranslated region to control Caspase-3 protein levels.

03

Biological functions

Apoptosis regulationPost-transcriptional regulationmRNA stabilityTranslation regulation
04

Disease associations

CancerNeurodegenerative diseaseIschemic strokeInflammationAutoimmune disease
05

Safety considerations

Off-target RNA bindingInnate immune activation by synthetic oligonucleotidesTissue-specific delivery challengesPotential for systemic toxicity due to widespread Caspase-3 roles
06

Interacting drugs

Experimental miR-21 inhibitors

3 more in the full profile.

07

Biomarkers

Caspase-3 protein expressionCaspase-3 mRNA levelsmiR-21 expression levelsCleaved PARP levels

Beyond the preview

Go deeper on Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) (CASP3 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) (CASP3 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call